Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
PLoS Pathog
    October 2026
  1. YAN S, Durringer A, Woottum M, Benichou S, et al
    HIV-1 cell-to-cell infection of macrophages escapes restriction by the BST-2 host cell factor independently of the Vpu counteracting viral protein.
    PLoS Pathog. 2026;22:e1014702.
    >> Share

  2. ZHANG Y, Wang P, Zhang J, Wang Y, et al
    KSHV K15 genetic heterogeneity is associated with Kaposi sarcoma aggressiveness through modulation of the host inflammatory microenvironment.
    PLoS Pathog. 2026;22:e1014615.
    >> Share

  3. WANG D, Ding W, Xu J, Li R, et al
    Structural basis of diverse substrate recruitment by the HIV-1 Vpr-hijacked CRL4(VprBP) E3 ligase.
    PLoS Pathog. 2026;22:e1014610.
    >> Share

  4. VISWANATHAN P, Bersonda JR, Gill J, Navarro A, et al
    The Mitochondrial ubiquitin ligase MARCHF5 cooperates with MCL1 to inhibit Apoptosis in KSHV-transformed primary effusion lymphoma cell lines.
    PLoS Pathog. 2026;22:e1014665.
    >> Share

  5. MANION M, Lange CM, Ortega-Villa AM, Fennessey CM, et al
    HIV-1 compartmentalization in the central nervous system during cryptococcal meningitis: Analysis of viral, fungal, and host factors.
    PLoS Pathog. 2026;22:e1014697.
    >> Share

  6. BODYKEVICH EG, Castello Casta F, Flynn JK, Nichols CA, et al
    Oral uracil treatment increases susceptibility to rectal SIV infection.
    PLoS Pathog. 2026;22:e1014716.
    >> Share

  7. HAMANN MV, Brauckmann L, Schwarz C, Spohn M, et al
    Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active proviruses.
    PLoS Pathog. 2026;22:e1014618.
    >> Share

    September 2026
  8. XU Y, Li M, Song Y, Kong W, et al
    NSUN2-mediated m5C modification of HIV-1 RNA enables evasion of RIG?I?dependent innate immunity.
    PLoS Pathog. 2026;22:e1014611.
    >> Share

    August 2026
  9. ZHOU P, Yuan M, Zhang Y, Limbo O, et al
    Directed evolution of a stem-helix-targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity.
    PLoS Pathog. 2026;22:e1014393.
    >> Share

  10. SANDSTROM K, Hagedorn GN, Robinson SC, Katz JE, et al
    Long-term depletion of KIR3DL01+ NK cells by adeno-associated viral-vectored antibody delivery alters chronic SIV infection.
    PLoS Pathog. 2026;22:e1014508.
    >> Share

    July 2026
  11. PIOTROWSKI SL, Li X, Fitzpatrick CE, Tucker A, et al
    Callitrichine herpesvirus 3 in the common marmoset is a model of Epstein-Barr virus infection and associated lymphoma.
    PLoS Pathog. 2026;22:e1014450.
    >> Share

  12. DHUMMAKUPT A, McFarland AG, Szewczyk J, Everett J, et al
    Quantification and localization of integrated HIV-1 in memory and naive CD4+ T cells from adolescents and young adults with perinatally-acquired HIV-1.
    PLoS Pathog. 2026;22:e1014369.
    >> Share

  13. ZHAO Y, Probert S, Birkel J, Liu X, et al
    Independent proviral and antiviral host factors recognize the same capsid protein in divergent human herpesviruses.
    PLoS Pathog. 2026;22:e1014376.
    >> Share

  14. RUIJTEN SDE, Dos Santos JC, Rios-Vazquez V, Navas A, et al
    Co-regulation of HIV control and cytomegalovirus pp65-specific IL-1beta and TNF-alpha responses by genetic variants in the MHC region.
    PLoS Pathog. 2026;22:e1014355.
    >> Share

  15. GRANT HE, Olabode AS, Seiler Vellame D, Poon AFY, et al
    Pervasive HIV recombination limits the utility of circulating recombinant form nomenclature.
    PLoS Pathog. 2026;22:e1014286.
    >> Share

  16. MAHDI M, Lakatos B, Motyan JA, Hoffka G, et al
    HIV capsid inhibitors: Mechanisms, resistance, and therapeutic advances.
    PLoS Pathog. 2026;22:e1014361.
    >> Share

  17. DAVE RS, Oludipe AA, Pasipanodya EC, Sherman S, et al
    The brain as an HIV reservoir: Recent findings using autopsy tissues from people with HIV.
    PLoS Pathog. 2026;22:e1014446.
    >> Share

  18. EDWARDS CT, Silva-Trenkle AD, Sahoo A, Cruickshank K, et al
    Non-human primate LIBRA-Seq accelerates neutralizing antibody discovery in RM vaccinated against HIV-1.
    PLoS Pathog. 2026;22:e1013831.
    >> Share

    June 2026
  19. TIAN M, Davis J, Cheng HL, Thompson LM, et al
    Maturation of HIV-1 neutralizing antibodies in a germinal center conditional expression mouse model.
    PLoS Pathog. 2026;22:e1014373.
    >> Share

  20. TRUNFIO M, Caballero G, Gomez-Moreno V, Mallal SA, et al
    Central Nervous System T-cell immune architecture, and not HIV burden, tracks with cognition under long-term viral suppression.
    PLoS Pathog. 2026;22:e1014351.
    >> Share

  21. MYERS A, Chandravanshi M, Whitmore LS, Kohrn BF, et al
    HIV-1 BG505 SOSIP immunization induced B cell expansion targeting the 465-glycan hole, with neutralizing antibodies exhibiting distinct binding modes and mechanisms of virus inhibition.
    PLoS Pathog. 2026;22:e1014268.
    >> Share

  22. MORAGA E, Climent N, Sanchez-Molina A, Vicens-Artes S, et al
    Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells.
    PLoS Pathog. 2026;22:e1014266.
    >> Share

  23. MAHMOUD RM, Hiyoshi M, Abdelnaser RA, Monde K, et al
    M-Sec promotes the production of infectious HIV-1 virus through the exocyst complex in macrophages.
    PLoS Pathog. 2026;22:e1013717.
    >> Share

    May 2026
  24. AZZEH M, Santos MF, Yokomizo AMK, Cha V, et al
    Nuclear transport of cytomegalovirus tegument protein pp65 through nucleoplasmic reticulum.
    PLoS Pathog. 2026;22:e1014224.
    >> Share

  25. PILLAY M, Choudhary MC, Deo R, Naumenko S, et al
    Extensive diversity and impact of drug-resistant HIV-1 variants in individuals with prior virologic failure.
    PLoS Pathog. 2026;22:e1014118.
    >> Share

  26. CUI N, Han X, Huang Q, Wang P, et al
    Acetylation-mediated regulation of ALV viral proteins: Implications for retroviral inhibition.
    PLoS Pathog. 2026;22:e1014229.
    >> Share

  27. LODDO A, Delobel P, Vellas C
    Positioning HIV SMRTcap within the HIV reservoir toolbox.
    PLoS Pathog. 2026;22:e1014257.
    >> Share


  28. Editorial Note: Recruitment of a SAP18-HDAC1 Complex into HIV-1 Virions and Its Requirement for Viral Replication.
    PLoS Pathog. 2026;22:e1014251.
    >> Share

    April 2026
  29. KOWARSKY M, Dalman M, Moufarrej MN, Okamoto J, et al
    Cell-free RNA reveals host and microbial correlates of broadly neutralizing antibody development against HIV.
    PLoS Pathog. 2026;22:e1014066.
    >> Share

  30. KORBER B, Seaman MS, Mkhize NN, Greene K, et al
    Contemporary HIV-1 envelope pseudovirus panels for detecting and assessing B cell lineages with broadly neutralizing antibody potential.
    PLoS Pathog. 2026;22:e1013739.
    >> Share

  31. OMOLE TE, Nguyen HM, Marcinow A, Jahan N, et al
    Pre-Human Immunodeficiency Virus (HIV) infection Th17 CD4+ T cells as predictors of early HIV disease progression.
    PLoS Pathog. 2026;22:e1013852.
    >> Share

    March 2026
  32. CHEN Y, Klute S, Bansal A, Sparrer KMJ, et al
    HIV-1 Vpr is targeted for degradation by autophagy.
    PLoS Pathog. 2026;22:e1014020.
    >> Share

    February 2026
  33. LARIOS R, Hossain MB, Brown R, Jeyachandran AV, et al
    B Cell Receptor's function in virus entry: Anti-SARS-CoV-2 B cell receptors can mediate viral entry in an ACE2-independent mechanism.
    PLoS Pathog. 2026;22:e1013946.
    >> Share

  34. KUMAR N, Ma Z, Long F, Bonam SR, et al
    Mechanistic insights and in vivo HIV suppression by the BRD4-targeting small molecule ZL0580.
    PLoS Pathog. 2026;22:e1013449.
    >> Share

    January 2026
  35. HONG J, Deshpande A, Thakare Y, Simonovsky L, et al
    The host protein cyclophilin A restricts nuclear entry of HIV-1 mutants by reducing the elasticity of the viral capsid.
    PLoS Pathog. 2026;22:e1013910.
    >> Share

  36. KIM Y, Anderson JL, Tumpach C, Solomon A, et al
    The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir.
    PLoS Pathog. 2026;22:e1013923.
    >> Share

  37. MUIR L, Suchanek O, Thomas P, Griffith SA, et al
    Multifaceted B cell response to transient HIV viremia in elite controllers.
    PLoS Pathog. 2026;22:e1013817.
    >> Share

  38. SVANBERG C, Prasad Mukku R, Besler SO, Hopkins FR, et al
    HIV-1 derived oligonucleotides induce a type I IFN/STING dependent immune suppression reversible by targeting IFNARI.
    PLoS Pathog. 2026;22:e1013868.
    >> Share

  39. SADRI G, Nadakal ST, Lauer W, Kos J, et al
    Development and validation of HIV SMRTcap for the characterization of HIV-1 reservoirs across tissues and subtypes.
    PLoS Pathog. 2026;22:e1013171.
    >> Share

  40. YAO L, Gao Y, Tian W, Ding H, et al
    Broadly neutralizing antibody responses in a Chinese acute HIV-1 infection cohort of men who have sex with men.
    PLoS Pathog. 2026;22:e1013822.
    >> Share

  41. MARTINEZ-MARTINEZ YB, Huante MB, Naqvi KF, Shah MN, et al
    HIV impairs and exploits pulmonary Th17 and Th22 cell-mediated immune responses to Mycobacterium tuberculosis.
    PLoS Pathog. 2026;22:e1013897.
    >> Share

  42. ZHOU C, He H, Zhang Y, Liu X, et al
    YAP Inhibits HIV-1 transcription and promotes HIV-1 latency by regulating E3 ubiquitin ligase UHRF1 mediated tat degradation.
    PLoS Pathog. 2026;22:e1013906.
    >> Share

    December 2025
  43. MCGEE K, Dowell A, Lauder S, Begum J, et al
    Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory study.
    PLoS Pathog. 2025;21:e1013803.
    >> Share

  44. CORNISH D, Jackson-Jones KA, Ling-Hu T, Simons LM, et al
    Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells.
    PLoS Pathog. 2025;21:e1013745.
    >> Share

  45. WALLIS ZK, Midkiff CC, Zhao M, Autissier P, et al
    Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS.
    PLoS Pathog. 2025;21:e1013180.
    >> Share

  46. MULLER NF, Wick RR, Judd LM, Williamson DA, et al
    Quantifying plasmid movement in drug-resistant Shigella species using phylodynamic inference.
    PLoS Pathog. 2025;21:e1013621.
    >> Share

  47. OLLERTON MT, Folkvord JM, Bush V, Parry DA, et al
    Lymphoid B cells upregulate HIV-1 ex vivo and are linked to its expression in vivo.
    PLoS Pathog. 2025;21:e1013661.
    >> Share

  48. CANNAC M, Zoladek J, Bribes I, Fresneau-Resende M, et al
    SAMD9L inhibits flavivirus translation independently of its capacity to trigger innate immune response.
    PLoS Pathog. 2025;21:e1013773.
    >> Share

    November 2025
  49. KALDHUSDAL V, Franzen Boger M, Burgener AD, Lajoie J, et al
    The cervicovaginal microbiome associates with spatially restricted host transcriptional signatures throughout the human ectocervical epithelium and submucosa.
    PLoS Pathog. 2025;21:e1013677.
    >> Share

  50. ZHENG WH, Lin SY, He ZL, Ni RZ, et al
    CHIP/STUB1 suppresses the transcription and latent reactivation of HIV-1 via the TRAF6-NF-kappaB-HIV-LTR axis.
    PLoS Pathog. 2025;21:e1013683.
    >> Share

  51. ZHANG Y, Klein K, Ratcliff A, Galappaththi SL, et al
    Correction: Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phe
    PLoS Pathog. 2025;21:e1013697.
    >> Share

  52. STRUYVE T, Pardons M, De Clercq J, Termote L, et al
    Evolution of the HIV-1 integration site landscape and inducible reservoir in early-treated people.
    PLoS Pathog. 2025;21:e1013702.
    >> Share

    October 2025
  53. GROSSKOPF AK, Tobiasson V, Krug LT
    Eph receptor tyrosine kinases are functional entry receptors for murine gammaherpesvirus 68.
    PLoS Pathog. 2025;21:e1013263.
    >> Share

  54. GROBBEN M, Reiss EIMM, Schriek AI, van der Straten K, et al
    Induction of HIV-1-specific antibody-mediated effector functions by native-like envelope trimers in humans.
    PLoS Pathog. 2025;21:e1013614.
    >> Share

  55. ALDUNATE M, Tyssen D, Johnson A, Latham CF, et al
    Lactic acid produced by optimal vaginal Lactobacillus spp. potently and specifically inactivates HIV-1 in vitro by targeting the viral RNA genome and reverse transcriptase.
    PLoS Pathog. 2025;21:e1013594.
    >> Share

  56. AHMAD I, Zhang J, Li R, Su W, et al
    Murine leukemia virus glycoGag antagonizes SERINC5 via ER-phagy receptor RETREG1.
    PLoS Pathog. 2025;21:e1013023.
    >> Share

    September 2025
  57. DERBY N, Johnson BI, Biswas S, Fischer M, et al
    Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsets.
    PLoS Pathog. 2025;21:e1013175.
    >> Share

  58. CHOSHI P, Pedretti S, Chimbetete T, Gangula R, et al
    The association of class II HLA alleles with tuberculosis-associated immune reconstitution inflammatory syndrome.
    PLoS Pathog. 2025;21:e1013497.
    >> Share

  59. PUERTAS MC, Bailon L, Urrea V, Garcia-Guerrero MC, et al
    Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy.
    PLoS Pathog. 2025;21:e1013466.
    >> Share

  60. RIVAULT A, Bernut A, Ben-Neji M, Abrantes M, et al
    HIV-1 Tat favors the multiplication of Mycobacterium tuberculosis and Toxoplasma by inhibiting clathrin-mediated endocytosis and autophagy.
    PLoS Pathog. 2025;21:e1013183.
    >> Share

  61. LEWIS CA, Margolis DM, Browne EP
    HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells.
    PLoS Pathog. 2025;21:e1013073.
    >> Share

  62. BUFFA DJ, O'Neil TR, Vine EE, Sarkawt L, et al
    Dendritic cells and HIV transmission: roles and subsets of antigen-presenting cells in the human anogenital tract.
    PLoS Pathog. 2025;21:e1013490.
    >> Share

  63. COLLERCANDY N, Vellas C, Nayrac M, Requena M, et al
    Cytotoxic CX3CR1+ Vdelta1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapy.
    PLoS Pathog. 2025;21:e1013489.
    >> Share

    August 2025
  64. ZEEB M, Kusejko K, Hartnack S, Pasin C, et al
    Infection with Mycobacterium tuberculosis alters the antibody response to HIV-1.
    PLoS Pathog. 2025;21:e1013350.
    >> Share

  65. LI G, Ma J, Yu H, Tsahouridis O, et al
    CD24-Fc resolves inflammation and enhances anti-HIV CD8 T cells with polyfunctionality during HIV-1 infection under ART.
    PLoS Pathog. 2025;21:e1012826.
    >> Share

  66. SERWIN K, Mielczak K, Urbanska A, Aksak-Was B, et al
    Comparison of HIV-1 A6 dispersal dynamics in Poland before and after the war in Ukraine.
    PLoS Pathog. 2025;21:e1013369.
    >> Share

  67. TANG Y, Xie L, Shabangu CS, Li D, et al
    Persistent type I interferon signaling within the brain of people with HIV on ART with cognitive impairment.
    PLoS Pathog. 2025;21:e1013411.
    >> Share


  68. Retraction: Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease.
    PLoS Pathog. 2025;21:e1013442.
    >> Share

    July 2025
  69. CHOUDHARY A, Mallick K, Dalavi R, Chande A, et al
    HIV-1 Vpr orchestrates ciTRAN upregulation through TGF-beta induction.
    PLoS Pathog. 2025;21:e1013332.
    >> Share

  70. RIST M, Kaku M, Coffin JM
    In vitro HIV DNA integration in STAT3 drives T cell persistence-A model of HIV-associated T cell lymphoma.
    PLoS Pathog. 2025;21:e1013087.
    >> Share

    June 2025
  71. NDLOVU B, Gounder K, Zikhali N, Singh L, et al
    Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies.
    PLoS Pathog. 2025;21:e1013245.
    >> Share

  72. MIYAKAWA K, Tanaka K, Ino Y, Kimura Y, et al
    PHD3-VHL axis controls HIV-2 infection through oxygen-dependent hydroxylation and degradation of Vpx.
    PLoS Pathog. 2025;21:e1013241.
    >> Share

  73. DESHPANDE A, Shi J, Rotem-Dai N, Aiken C, et al
    Reverse transcription progression and genome length regulate HIV-1 core elasticity and disassembly.
    PLoS Pathog. 2025;21:e1013269.
    >> Share

  74. SWITZER WM, Zheng H, Muniz CP, Pan Y, et al
    High prevalence of simian foamy virus infection of South American Indians.
    PLoS Pathog. 2025;21:e1013169.
    >> Share

  75. LAWRENCE LA, Williams ME, Vidal P, Varughese RS, et al
    Murine modeling of menstruation identifies immune correlates of protection during Chlamydia muridarum challenge.
    PLoS Pathog. 2025;21:e1012276.
    >> Share

    May 2025
  76. AGRAWAL P, Khechaduri A, Salladay KR, MacCamy A, et al
    Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-like antibodies.
    PLoS Pathog. 2025;21:e1013039.
    >> Share

  77. ZHANG Y, Klein K, Ratcliff A, Galappaththi SL, et al
    Transmitted/founder (T/F) HIV-1 derived from sexual contact exhibits greater transmission fitness in human cervical tissue than T/F HIV-1 from blood-to-blood contact: Unique glycan profiles on T/F envelopes associated with transmission phenotypes.
    PLoS Pathog. 2025;21:e1013177.
    >> Share

  78. DZHIVHUHO GA, Jackson PEH, Honeycutt ES, Mesquita FDS, et al
    Rev-RRE activity modulates HIV-1 replication and latency reactivation: Implications for viral persistence and cure strategies.
    PLoS Pathog. 2025;21:e1012885.
    >> Share

    April 2025
  79. WOOTTUM M, Yan S, Durringer A, Meziere L, et al
    HIV-1 cell-to-cell infection of macrophages escapes type I interferon and host restriction factors, and is resistant to antiretroviral drugs.
    PLoS Pathog. 2025;21:e1013130.
    >> Share

  80. MARTIN MA, Brizzi A, Xi X, Galiwango RM, et al
    Quantifying prevalence and risk factors of HIV multiple infection in Uganda from population-based deep-sequence data.
    PLoS Pathog. 2025;21:e1013065.
    >> Share

  81. BUCHANAN LB, Shao Z, Galiwango RM, Constable S, et al
    HIV-associated penile anaerobes disrupt epithelial barrier integrity.
    PLoS Pathog. 2025;21:e1013094.
    >> Share

  82. FAIZO AAA, Bellward C, Hernandez-Lopez HR, Stevenson A, et al
    The splicing factor kinase, SR protein kinase 1 (SRPK1) is essential for late events in the human papillomavirus life cycle.
    PLoS Pathog. 2025;21:e1012697.
    >> Share

  83. ASHOKKUMAR M, Hafer TL, Felton A, Archin NM, et al
    A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latency.
    PLoS Pathog. 2025;21:e1012467.
    >> Share

  84. REEVES DB, Litchford M, Fish CS, Farrell-Sherman A, et al
    Intact HIV DNA decays in children with and without complete viral load suppression.
    PLoS Pathog. 2025;21:e1013003.
    >> Share

  85. ZHAO W, Modak A, Ross SR
    DHX15 inhibits mouse APOBEC3 deamination.
    PLoS Pathog. 2025;21:e1013045.
    >> Share

  86. SARKAR S, Kobayashi Y, Russnak T, Shen J, et al
    GS143, an inhibitor of E3 ligase beta-TrCP, reverses HIV-1 latency without activating T cells via unconventional activation of NFkappaB.
    PLoS Pathog. 2025;21:e1013018.
    >> Share

  87. NOORSAEED S, AlBurtamani N, Rokan A, Fassati A, et al
    Heat shock protein 90 is a chaperone regulator of HIV-1 latency.
    PLoS Pathog. 2025;21:e1012524.
    >> Share

    March 2025
  88. NAIR A, Davis DA, Warner A, Karim B, et al
    The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter region.
    PLoS Pathog. 2025;21:e1012984.
    >> Share

  89. CANDOR K, Ding L, Balchand S, Hammonds JE, et al
    The CLIC/GEEC pathway regulates particle uptake and formation of the virus-containing compartment (VCC) in HIV-1-infected macrophages.
    PLoS Pathog. 2025;21:e1012564.
    >> Share

    February 2025
  90. IRRINKI AM, Kaur J, Randhawa B, McFadden R, et al
    Activating PKC-epsilon induces HIV expression with improved tolerability.
    PLoS Pathog. 2025;21:e1012874.
    >> Share

    January 2025
  91. GRIFFITH GL, Machmach K, Jian N, Kim D, et al
    CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadth.
    PLoS Pathog. 2025;21:e1012916.
    >> Share

  92. SCOTT TM, Arnold LM, Powers JA, McCann DA, et al
    Cell-free assays reveal that the HIV-1 capsid protects reverse transcripts from cGAS immune sensing.
    PLoS Pathog. 2025;21:e1012206.
    >> Share

  93. HUANG SW, Briganti L, Annamalai AS, Greenwood J, et al
    The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir.
    PLoS Pathog. 2025;21:e1012862.
    >> Share

  94. HUBAL A, Vendhoti A, Shaffer CN, Vos S, et al
    Inhibition of Src signaling induces autophagic killing of Toxoplasma gondii via PTEN-mediated deactivation of Akt.
    PLoS Pathog. 2025;21:e1012907.
    >> Share

  95. EDWARDS CT, Karunakaran KA, Garcia E, Beutler N, et al
    Passive infusion of an S2-Stem broadly neutralizing antibody protects against SARS-CoV-2 infection and lower airway inflammation in rhesus macaques.
    PLoS Pathog. 2025;21:e1012456.
    >> Share

  96. FOULKES C, Friedrich N, Ivan B, Stiegeler E, et al
    Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity.
    PLoS Pathog. 2025;21:e1012825.
    >> Share

  97. ROHLFES N, Radhakrishnan R, Singh PK, Bedwell GJ, et al
    The nuclear localization signal of CPSF6 governs post-nuclear import steps of HIV-1 infection.
    PLoS Pathog. 2025;21:e1012354.
    >> Share

  98. FARINRE O, Anaya T, King AC, Endrias K, et al
    SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.
    PLoS Pathog. 2025;21:e1012863.
    >> Share

  99. MAN S, Jansen J, Kroeze S, Geijtenbeek TBH, et al
    Transcriptomic HIV-1 reservoir profiling reveals a role for mitochondrial functionality in HIV-1 latency.
    PLoS Pathog. 2025;21:e1012822.
    >> Share

  100. HU K, O'Neil TR, Baharlou H, Austin PJ, et al
    The spatial biology of HIV infection.
    PLoS Pathog. 2025;21:e1012888.
    >> Share

    December 2024
  101. MAK NSC, Liu J, Zhang D, Taylor J, et al
    Alternative splicing expands the antiviral IFITM repertoire in Chinese rufous horseshoe bats.
    PLoS Pathog. 2024;20:e1012763.
    >> Share

  102. GROBBEN M, Bakker M, Schriek AI, Levels LJJ, et al
    Polyfunctionality and breadth of HIV-1 antibodies are associated with delayed disease progression.
    PLoS Pathog. 2024;20:e1012739.
    >> Share

  103. RADER AG, Cloherty APM, Patel KS, Almandawi DDA, et al
    HIV-1 exploits LBPA-dependent intraepithelial trafficking for productive infection of human intestinal mucosa.
    PLoS Pathog. 2024;20:e1012714.
    >> Share

  104. RICHEL E, Cordsmeier A, Bauer L, Fraedrich K, et al
    Mechanisms of sterilizing immunity provided by an HIV-1 neutralizing antibody against mucosal infection.
    PLoS Pathog. 2024;20:e1012777.
    >> Share

    November 2024
  105. FRANZEN BOGER M, Hasselrot T, Kaldhusdal V, Miranda GHB, et al
    Sustained immune activation and impaired epithelial barrier integrity in the ectocervix of women with chronic HIV infection.
    PLoS Pathog. 2024;20:e1012709.
    >> Share

    October 2024
  106. SNOW BJ, Keles NK, Grunst MW, Janaka SK, et al
    Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells.
    PLoS Pathog. 2024;20:e1012665.
    >> Share

  107. JIANG P, Majerciak V, Hu J, Balogh K, et al
    The full transcription map of cottontail rabbit papillomavirus in tumor tissues.
    PLoS Pathog. 2024;20:e1012649.
    >> Share

  108. HOWARD JN, Levinger C, Deletsu S, Fromentin R, et al
    Isotretinoin promotes elimination of translation-competent HIV latent reservoirs in CD4T cells.
    PLoS Pathog. 2024;20:e1012601.
    >> Share

  109. BRINKKEMPER M, Kerster G, Brouwer PJM, Tran AS, et al
    Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes.
    PLoS Pathog. 2024;20:e1012558.
    >> Share

    September 2024
  110. DAS MK, Savidge B, Pearl JE, Yates T, et al
    Altered hepatic metabolic landscape and insulin sensitivity in response to pulmonary tuberculosis.
    PLoS Pathog. 2024;20:e1012565.
    >> Share

  111. HU Z, Cinque P, Dravid A, Hagberg L, et al
    Changes in cerebrospinal fluid proteins across the spectrum of untreated and treated chronic HIV-1 infection.
    PLoS Pathog. 2024;20:e1012470.
    >> Share

  112. CHEN YA, Vickers EN, Aranda-Diaz A, Murphy M, et al
    Genomic epidemiology demonstrates spatially clustered, local transmission of Plasmodium falciparum in forest-going populations in southern Lao PDR.
    PLoS Pathog. 2024;20:e1012194.
    >> Share

  113. PETRARA MR, Ruffoni E, Carmona F, Cavallari I, et al
    HIV reservoir and premature aging: risk factors for aging-associated illness in adolescents and young adults with perinatally acquired HIV.
    PLoS Pathog. 2024;20:e1012547.
    >> Share

  114. XU X, Niu M, Lamberty BG, Emanuel K, et al
    Microglia and macrophages alterations in the CNS during acute SIV infection: A single-cell analysis in rhesus macaques.
    PLoS Pathog. 2024;20:e1012168.
    >> Share

  115. CISNEROS WJ, Soliman SHA, Walter M, Simons LM, et al
    Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.
    PLoS Pathog. 2024;20:e1012083.
    >> Share

  116. DESHPANDE A, Bryer AJ, Andino-Moncada JR, Shi J, et al
    Elasticity of the HIV-1 core facilitates nuclear entry and infection.
    PLoS Pathog. 2024;20:e1012537.
    >> Share

  117. ALTMAN PX, Ozorowski G, Stanfield RL, Haakenson J, et al
    Immunization of cows with HIV envelope trimers generates broadly neutralizing antibodies to the V2-apex from the ultralong CDRH3 repertoire.
    PLoS Pathog. 2024;20:e1012042.
    >> Share

  118. JENNINGS J, Bracey H, Hong J, Nguyen DT, et al
    The HIV-1 capsid serves as a nanoscale reaction vessel for reverse transcription.
    PLoS Pathog. 2024;20:e1011810.
    >> Share

  119. ZHANG Y, Otte F, Stoeckle M, Thielen A, et al
    HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond.
    PLoS Pathog. 2024;20:e1012526.
    >> Share

  120. VUKOVICH MJ, Shiakolas AR, Lindenberger J, Richardson RA, et al
    Isolation and characterization of IgG3 glycan-targeting antibodies with exceptional cross-reactivity for diverse viral families.
    PLoS Pathog. 2024;20:e1012499.
    >> Share

  121. SIMPSON J, Dulek B, Schaughency P, Brenchley JM, et al
    Multi-omics analysis of SIV-specific CD8+ T cells in multiple anatomical sites.
    PLoS Pathog. 2024;20:e1012545.
    >> Share

    August 2024
  122. VARCO-MERTH B, Chaunzwa M, Duell DM, Marenco A, et al
    Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
    PLoS Pathog. 2024;20:e1012496.
    >> Share

  123. ZHOU Z, Guo J, Hetrick B, Tiwari S, et al
    Characterization of a CXCR4 antagonist TIQ-15 with dual tropic HIV entry inhibition properties.
    PLoS Pathog. 2024;20:e1012448.
    >> Share

  124. VAN DER STRATEN K, Guerra D, Kerster G, Claireaux M, et al
    Primary SARS-CoV-2 variant of concern infections elicit broad antibody Fc-mediated effector functions and memory B cell responses.
    PLoS Pathog. 2024;20:e1012453.
    >> Share

  125. NEUNER-JEHLE N, Zeeb M, Thorball CW, Fellay J, et al
    Using viral diversity to identify HIV-1 variants under HLA-dependent selection in a systematic viral genome-wide screen.
    PLoS Pathog. 2024;20:e1012385.
    >> Share

  126. JAMAL EDDINE J, Angelovich TA, Zhou J, Byrnes SJ, et al
    HIV transcription persists in the brain of virally suppressed people with HIV.
    PLoS Pathog. 2024;20:e1012446.
    >> Share

  127. XU S, Li H, Ai Z, Guo R, et al
    Exploring viral neuropathic pain: Molecular mechanisms and therapeutic implications.
    PLoS Pathog. 2024;20:e1012397.
    >> Share

    July 2024
  128. PHAN T, Conway JM, Pagane N, Kreig J, et al
    Understanding early HIV-1 rebound dynamics following antiretroviral therapy interruption: The importance of effector cell expansion.
    PLoS Pathog. 2024;20:e1012236.
    >> Share

  129. UMTHONG S, Timilsina U, D'Angelo MR, Salka K, et al
    MARCH2, a T cell specific factor that restricts HIV-1 infection.
    PLoS Pathog. 2024;20:e1012330.
    >> Share

  130. MARSHALL VA, Cornejo Castro EM, Goodman CA, Labo N, et al
    Sequencing of Kaposi's Sarcoma Herpesvirus (KSHV) genomes from persons of diverse ethnicities and provenances with KSHV-associated diseases demonstrate multiple infections, novel polymorphisms, and low intra-host variance.
    PLoS Pathog. 2024;20:e1012338.
    >> Share

  131. AL-KAABI M, Deshpande P, Firth M, Pavlos R, et al
    Epistatic interaction between ERAP2 and HLA modulates HIV-1 adaptation and disease outcome in an Australian population.
    PLoS Pathog. 2024;20:e1012359.
    >> Share

    June 2024
  132. WARNER VAN DIJK FA, Tong O, O'Neil TR, Bertram KM, et al
    Characterising plasmacytoid and myeloid AXL+ SIGLEC-6+ dendritic cell functions and their interactions with HIV.
    PLoS Pathog. 2024;20:e1012351.
    >> Share

  133. BUSSEY-SUTTON CR, Ward A, Fox JA, Turner AW, et al
    The histone methyltransferase SETD2 regulates HIV expression and latency.
    PLoS Pathog. 2024;20:e1012281.
    >> Share

    May 2024
  134. KARSTEN CB, Buettner FFR, Cajic S, Nehlmeier I, et al
    Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity.
    PLoS Pathog. 2024;20:e1012190.
    >> Share

  135. AMORIM SACRAMENTO L, Farias Amorim C, G Lombana C, Beiting D, et al
    CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.
    PLoS Pathog. 2024;20:e1012211.
    >> Share

  136. WINDELS EM, Wampande EM, Joloba ML, Boom WH, et al
    HIV co-infection is associated with reduced Mycobacterium tuberculosis transmissibility in sub-Saharan Africa.
    PLoS Pathog. 2024;20:e1011675.
    >> Share

  137. WILHELM E, Poirier M, Da Rocha M, Bedard M, et al
    Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
    PLoS Pathog. 2024;20:e1011821.
    >> Share

  138. MANICKAM C, Upadhyay AA, Woolley G, Kroll KW, et al
    Natural killer-like B cells are a distinct but infrequent innate immune cell subset modulated by SIV infection of rhesus macaques.
    PLoS Pathog. 2024;20:e1012223.
    >> Share

    April 2024
  139. KUZMINA A, Sadhu L, Hasanuzzaman M, Fujinaga K, et al
    Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression.
    PLoS Pathog. 2024;20:e1012172.
    >> Share

  140. KEELE BF, Okoye AA, Fennessey CM, Varco-Merth B, et al
    Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
    PLoS Pathog. 2024;20:e1012135.
    >> Share

  141. WONG RW, Balachandran A, Cheung PK, Cheng R, et al
    Correction: An activator of G protein-coupled receptor and MEK1/2-ERK1/2 signaling inhibits HIV-1 replication by altering viral RNA processing.
    PLoS Pathog. 2024;20:e1012155.
    >> Share

    March 2024
  142. LAYISH B, Goli R, Flick H, Huang SW, et al
    Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
    PLoS Pathog. 2024;20:e1011830.
    >> Share

  143. ZHANG X, Hu Y, Vandenhoudt RE, Yan C, et al
    Computationally inferred cell-type specific epigenome-wide DNA methylation analysis unveils distinct methylation patterns among immune cells for HIV infection in three cohorts.
    PLoS Pathog. 2024;20:e1012063.
    >> Share

    February 2024
  144. JOSEPH SB, Abrahams MR, Moeser M, Tyers L, et al
    The timing of HIV-1 infection of cells that persist on therapy is not strongly influenced by replication competency or cellular tropism of the provirus.
    PLoS Pathog. 2024;20:e1011974.
    >> Share

  145. BENNETT SJ, Yalcin D, Privatt SR, Ngalamika O, et al
    Antibody profiling and predictive modeling discriminate between Kaposi sarcoma and asymptomatic KSHV infection.
    PLoS Pathog. 2024;20:e1012023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016